ArticleNMR in biomedicine2019
Response to re: Metabolomic prostate cancer fields in HRMAS MRS-profiled histologically benign tissue vary with cancer status and distance from cancer. Dinges et al., NBM 2019.
Leo L ChengPubMed ↗Publisher ↗
No numbers read from the abstract.